References
- 1. Moulton, J.E. (1990). Tumors of the mammary gland. In: Moulton J.E. (Ed.), Tumours in domestic animals (pp. 518–552). Berkeley: University of California Press.
- 2. Sorenmo, K. (2003). Canine mammary gland tumors. Vet Clin North Am Small Anim Pract. 33, 573–596. http://dx.doi.org/10.1016/S0195-5616(03)00020-2
- 3. Hellmen, E. (2005). Complex mammary tumours in the female dog: a review. Journal of Dairy Research 72, 90–97. http://dx.doi.org/10.1017/S002202990500124X PMid:16180726
- 4. Sorenmo, K.U., Kristiansen, V.M., Cofone, M.A., Shofer, F.S., Breen, A.M., Langeland, M., Mongil, C.M., Grondahl, A.M., Teige, J., Goldschmidt, M.H. (2009). Canine mammary gland tumours: a histological continuum from benign to malignant, clinical and histopathological evidence. Vet Comp Oncol. 7, 162–172. http://dx.doi.org/10.1111/j.1476-5829.2009.00184.x PMid:19691645
- 5. Misdorp, W. (2002). Tumors of the mammary gland. In: Meuten D.J. (Ed.), Tumors in domestic animals (pp. 575–606). Ames: Iowa State Press. http://dx.doi.org/10.1002/9780470376928.ch12
- 6. MacEwen, E.G., Withrow, S. (1996). Tumors of the mammary gland. Small Animal Oncology (pp. 356–372). Philadelphia: Saunders Company.
- 7. De Las Mulas, J. M., Millán, Y., Dios, R. (2005). A prospective analysis of immunohistochemically determined estrogen receptor α and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog. Veterinary Pathology Online 42 (2): 200-212. http://dx.doi.org/10.1354/vp.42-2-200 PMid:15753474
- 8. Nieto, A., Pena, L., Pérez-Alenza, M. D., Sanchez, M. A., Flores, J.M., Castano, M. (2000). Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance. Vet Pathol. 37 (3): 239–247. http://dx.doi.org/10.1354/vp.37-3-239 PMid:10810988
- 9. Lana, S.E., Rutteman, G.R., Withrow, S.J. (2007). Tumors of the mammary gland. In: Withrow S.J & MacEwen B.R. (Ed.), Small animal clinical oncology (pp. 455-477). Philadelphia: Saunders Company. http://dx.doi.org/10.1016/B978-072160558-6.50029-0
- 10. Murphy, S. (2008). Mammary tumours in dogs and cats. Inpractice 6, 334–339. http://dx.doi.org/10.1136/inpract.30.6.334
- 11. Beauvais, W., Cardwell, J. M., Brodbelt, D. C. (2012). The effect of neutering on the risk of mammary tumours in dogs – a systematic review. J Small Anim Pract. 53, 314–322. http://dx.doi.org/10.1111/j.1748-5827.2011.01220.x PMid:22647210
- 12. Las Mulas, J.M., Millan, Y., Dios R. (2005). A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog. Vet Pathol. 42, 200-212. http://dx.doi.org/10.1354/vp.42-2-200 PMid:15753474
- 13. Cork, D. M. W., Lennard, T. W. J., Tyson-Capper, A. J. (2008). Alternative splicing and the progesterone receptor in breast cancer. Breast Cancer Res. 10 (3): 207. http://dx.doi.org/10.1186/bcr2097 PMid:18557990 PMCid:PMC2481493
- 14. Misdorp, W., Hellmen, E., Else, R.W. (1999). Mammary tumours and dysplasia in dogs and cats. Histologic classification of tumours of domestic animals. Second series (pp. 3-6). Washington DC: Armed Forces Institute of Pathology.
- 15. Sorenmo, K.U., Shoferm, F.S., Goldschmidt, M.H. (2000). Effect of spaying and timing of spaying on survival of dogs with mammary carcinoma. J Vet Intern Med. 14, 266–270. http://dx.doi.org/10.1111/j.1939-1676.2000.tb01165.x PMid:10830539
- 16. Thuroczy, J., Reisvaag, G. J. K., Perge, E., Tibold, A., Szilagyi, J., Balogh, L. (2007). Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours. J Comp Pathol. 137 (2-3): 122–129. http://dx.doi.org/10.1016/j.jcpa.2007.05.005 PMid:17645888
- 17. Diaz, L. K., Sneige, N. (2005). Estrogen receptor analysis for breast cancer: current issues and keys to increasing testing accuracy. Adv Anat Pathol. 12 (1): 10–19. http://dx.doi.org/10.1097/00125480-200501000-00003 PMid:15614160
- 18. Port Louis, L.R., Varshney, K.C., Nair, M.G. (2012). An immunohistochemical study on the expression of sex steroid receptors in canine mammary tumors. ISRN VetSci. 1-7. http://dx.doi.org/10.5402/2012/378607 PMid:23738123 PMCid:PMC3658582
- 19. Rutteman, G.R., Misdorpl, W., Blankenstein, M.A., Van den Brom, W.E. (1988). Oestrogen (ER) and progestin receptors (PR) in mammary tissue of the female dog: Different receptor profile in non-malignant and malignant states. Br J Cancer. 58, 594-599. http://dx.doi.org/10.1038/bjc.1988.266 PMid:3219269 PMCid:PMC2246835
- 20. Mariotti, F., Giacomo, R., Subeide, M. (2013). Immunohistochemical evaluation of ovarian hormonal receptors in canine mammary tumors. Open J Vet Med. 3, 104-110. http://dx.doi.org/10.4236/ojvm.2013.32017
- 21. Spoerri, M., Guscetti, F., Hartnack, S., Boos, A., Oei, C., Balogh, O., Nowaczyk, R. M., Michel, E., Reichler, I. M., Kowalewski, M. P. (2015). Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors. BMC Vet Res. 11, 235. http://dx.doi.org/10.1186/s12917-015-0546-y PMid:26370564 PMCid:PMC4570623
- 22. Chen, Y.M., Lee, C.S., Wright, P.J. (2006). The roles of progestagen and uterine irritant in the maintenance of cystic endometrial hyperplasia in the canine uterus. Theriogenology 66, 1537–1544. http://dx.doi.org/10.1016/j.theriogenology.2006.01.019 PMid:16472854
- 23. Hagman, R. (2014). Diagnostic and prognostic markers for uterine diseases in dogs. Reprod Dom Anim. 49 (2): 16–20. http://dx.doi.org/10.1111/rda.12331 PMid:24947856
- 24. Queiroga, F.L., Perez-Alenza, M.D., Silvan, G., Pena, L., Lopes, C., Illera, J.C. (2005). Role of steroid hormones and prolactin in canine mammary cancer. J Steroid Biochem Mol Biol. 94, 181–187. http://dx.doi.org/10.1016/j.jsbmb.2004.12.014 PMid:15862964